Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
61
-
Total shares
-
12.8M
-
Shares change
-
-30.2K
-
Total reported value, excl. options
-
$71.9M
-
Value change
-
-$90.2K
-
Put/Call ratio
-
0
-
Number of buys
-
18
-
Number of sells
-
-28
-
Price
-
$5.60
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q2 2016
62 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q2 2016.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.8M shares
.
Largest 10 shareholders include Wildcat Capital Management, LLC (2.8M shares), Cormorant Asset Management, LLC (2.12M shares), venBio Select Advisor LLC (1.66M shares), VANGUARD GROUP INC (968K shares), BlackRock Fund Advisors (746K shares), BlackRock Institutional Trust Company, N.A. (627K shares), STATE STREET CORP (481K shares), NORTHERN TRUST CORP (366K shares), FRANKLIN RESOURCES INC (339K shares), and SABBY MANAGEMENT, LLC (254K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.